1732 Organometallics, Vol. 28, No. 6, 2009
Arrowsmith et al.
7.05 (s, 1H, ring-CHdCHNMes), 6.98 (s, 2H, Ar-m-H), 3.67 (br.
s, 2H, BH2), 2.33 (s, 3H, p-CH3), 2.04 (s, 6H, o-CH3). 13C{1H}
NMR ppm (CDCl3, 298 K): 141.1 (ring-NCHN), 140.2 (Ar-i-C),
134.8 (ring-CHdCHNMes), 130.1 (Ar-m-C), 126.8 (Ar-p-C), 123.2
(Ar-o-C), 115.1 (ring-CHdCHNMes), 21.5 (p-CH3), 18.2 (o-CH3).
11B{1H} NMR ppm (CDCl3, 298 K): -6.10. IR (Nujol): υB-H 2444
cm-1, br. Anal. Calcd for C24H30BIN4: C, 56.27; H, 5.90; N, 10.94%.
Found: C, 56.7; H, 5.89; N, 10.7%.
[H2B(ImMes)2]Br, 4. 1-mesityl-imidazole (2.00 g, 10.74 mmol)
and Me3N.BH2Br (0.82 g, 5.37 mmol). Crystallized from CHCl3:
white solid (1.30 g, 52%), mp 190-192 °C. 1H NMR ppm (CDCl3,
298 K): 9.55 (s, 1H, ring-NCHN), 7.60 (s, 1H, ring-CHdCHNMes),
7.00 (s, 1H, ring-CHdCHNMes), 6.97 (s, 2H, Ar-m-H), 2.32 (s,
3H, p-CH3), 2.04 (s, 6H, o-CH3). 13C{1H} NMR ppm (CDCl3, 298
K): 140.4 (ring-NCHN), 140.3 (Ar-i-C), 134.3 (Ar-m-C), 129.4
(ring-CHdCHNMes), 126.1 (Ar-p-C), 122.1 (Ar-o-C), 114.4 (ring-
CHdCHNMes), 20.9 (p-CH3), 17.4 (o-CH3). 11B{1H} NMR ppm
(CDCl3, 298 K): -7.90. IR (Nujol): υB-H 2441 cm-1, br. Anal.
Calcd for C24H30BBrN4: C, 61.91; H, 6.50; N, 12.04%. Found: C,
61.7; H, 6.48; N, 11.9%.
(nonagostic B-H), 2252 (agostic B-H) cm-1. Anal. Calcd for
C29.5H61.5BN5O2Si2Sr (937.82): C, 52.63; H, 9.21; N, 10.41%.
Found: C, 52.75; H, 9.43; 10.33.
[{H2B(ImtBu)2}2Ca(THF)], 7. Redistribution product from the
attempted synthesis of [{H2B(ImtBu)2}CaI(THF)]: Compound 1
(0.50 g, 1.29 mmol), calcium iodide (0.38 g, 1.29 mmol) and
KN(SiMe3)2 (0.51 g, 2.58 mmol): colorless crystals after 3 days at
-20 °C (0.20 g, 49% based on CaI2). 1H NMR/ ppm (C6D6): 7.26
3
3
(d, 4H, J ) 1.5 Hz, ring-CHdCHNtBu), 6.60 (d, 4H, J ) 1.5
Hz, ring-CHdCHNtBu), 4.44 (br. s, 2H, BH2), 3.59 (m, 4H, THF),
1.38 (m, 4H, THF), 1.36 (s, 36H, CH3). 13C{1H} NMR ppm (C6D6,
298 K): 195.0 (carbene-C), 124.0 (ring-CHdCHNtBu), 113.3 (ring-
CHdCHNtBu), 66.7 (THF), 53.8 (CCH3), 30.0 (THF), 24.3 (CH3).
11B{1H} NMR ppm (C6D6, 298 K): -5.42. IR (Nujol): υB-H 2363
(nonagostic B-H), 2255 (agostic B-H) cm-1
.
[{H2B(ImtBu)2}2Sr(THF)2], 8. Redistribution product from the
attempted synthesis of [{H2B(ImtBu)2}SrI(THF)]2: Compound 1
(0.50 g, 1.29 mmol), strontium iodide (0.44 g, 1.29 mmol) and
KN(SiMe3)2 (0.51 g, 2.58 mmol): colorless crystals after 3 days at
-20 °C (0.21 g, 43%). Loses one molecule of THF on isolation.
1H NMR ppm (C6D6, 298 K): 7.29 (d, 4H, 3J ) 1.5 Hz,
ring-CHdCHNtBu), 6.63 (d, 4H, 3J ) 1.5 Hz, ring-CHdCHNtBu),
4.44 (br. s, 2H, BH2), 3.67 (m, 4H, THF), 1.30 (s, 36H, CH3), 1.30
(m, 4H, THF). 13C{1H} NMR ppm (C6D6 298 K): 198.9 (carbene-
C), 124.3 (ring-CHdCHNtBu), 113.1 (ring-CH dbd)CHNtBu), 67.2
(THF), 53.7 (CCH3), 30.0 (THF), 24.2 (CH3). 11B{1H} NMR ppm
(C6D6 298 K): -5.64.
Synthesis of Bis(imidazolyl-2-ylidenyl)borate Alkaline Earth
Compounds 5-8. General Procedure. In a glovebox, the ap-
propriate ligand precursor (1-4), calcium iodide and potassium
bis(trimethylsilyl)amide were weighed at a 1:1:3 or 4 ratio into a
dry Schlenk flask. Dry THF was added at -78 °C and the mixture
was left to stir at room temperature overnight until the calcium
iodide beads had been consumed. The solvent was removed in
Vacuo and hexane/toluene added. The resultant milky solution was
stirred for another hour then allowed to settle prior to filtration and
concentration of the solution to incipient crystallization. After 3-7
days at -20 °C, the mother liquor was filtered into a second Schlenk
and the transparent crystals completely dried on vacuum line.
Samples suitable for X-ray diffraction analyses were selected under
a cryogenic flow of dinitrogen to prevent melting at ambient
temperatures.
[{H2B(ImMes)2}Ca{N(SiMe3)2}(THF)], 9. Compound 3 (0.74
g, 1.46 mmol), [Ca{N(SiMe3)2}2(THF)2] (0.50 g, 0.98 mmol): light-
pink powder (0.14 g, 50%). 1H NMR ppm (C6D6 298 K): 7.21 (d,
3
2H, J ) 1.5 Hz, ring-CHdCHNMes), 6.77 (s, 4H, Ar-H), 6.27
3
(d, 2H, J ) 1.5 Hz, ring-CHdCHNMes), 4.41 (br. s, 2H, BH2),
3.52 (m, 4H, THF), 2.12 (s, 6H, Ar-p-CH3), 1.93 (s, 2H, Ar-o-
CH3), 1.14 (m, 4H, THF), 0.12 (s, 18H, Si(CH3)3). 13C{1H} NMR
ppm (C6D6 298 K): 196.0 (carbene-C), 137.1 (Ar-i-C), 136.2 (Ar-
m-C), 135.0 (Ar-p-C), 128.2 (Ar-o-C), 123.6 (ring-CHdCHNMes),
117.7 (ring-CHdCHNMes), 67.6 (THF), 23.7 (THF), 19.6 (Ar-p-
CH3), 16.4 (Ar-o-CH3), 3.9 (Si(CH3)3). 11B{1H} NMR ppm (C6D6
298 K): -5.87.
[{H2B(ImtBu)2}Ca{N(SiMe3)2}(THF)], 5. (a)Compound 2 (2.08
g, 6.1 mmol), calcium iodide (1.79 g, 6.1 mmol) and KN(SiMe3)2
(3.66 g, 18.3 mmol): pale yellow transparent solid, very air- and
temperature- sensitive, oily solid at 21 °C; crystalline at -16 °C
(0.55 g, 18%). (b) Compound 1 (2.00 g, 5.2 mmol), calcium iodide
(1.51 g, 5.2 mmol) and KN(SiMe3)2 (3.08 g, 15.5 mmol): off-white
powder (1.55 g, 56%). 1H NMR ppm (C6D6, 298 K): 7.23 (d, 2H,
ring-CHdCHNtBu, 3J ) 1.5 Hz), 7.13 (s, 2H, ring-CHdCHNtBu),
Crystallographic Data. Data for 1, 3, 6, 7 and 10 were collected
at 150 K on a Nonius KappaCCD diffractometer equipped with an
Oxford Cryosystem, using graphite monochromated Mo KR radia-
tion (λ ) 0.71073 Å). Data were processed using the Nonius
Software.16
3
6.59 (d, 2H, ring-CHdCHNtBu, J ) 1.5 Hz), 6.52 (s, 2H, ring-
For 1, 3, 6 and 10 a symmetry-related (multiscan) absorption
correction had been applied. Crystal parameters and details on data
collection, solution and refinement for the complexes are provided
in Table 1. Structure solution, followed by full-matrix least-squares
refinement was performed using the WINGX-1.70 suite of programs
throughout.18
CHdCHNtBu), 4.31 (br. s, 2H, BH2), 3.63 (m, 4H, THF), 1.36
(m, 4H, THF), 1.31 (s, 18H, CH3), 0.45 (broad s, 18H, Si(CH3)3).
13C{1H} NMR ppm (C6D6, 298 K): 195.0, (carbene-C), 125.0, (ring-
CHdCHNtBu), 114.4 (ring-CHdCHNtBu), 68.6 (THF), 54.8
(THF), 31.1 (CCH3), 25.0 (CCH3), 2.3 (Si(CH3)3). 11B{1H} NMR
ppm (C6D6, 298 K): -5.8. In d8-toluene, the imidazol-2-ylidene
1H NMR signals split at low temperatures. IR (Nujol): υB-H 2385
(non agostic B-H), 2252 (agostic B-H) cm-1. Anal. Calcd for
C24H52BCaN5OSi2 (533.8): C, 54.00; H, 9.82; N, 13.12%. Found:
C, 54.09; H, 9.41; 13.23.
For compounds 1 and 3 the -BH2 hydrogen atoms were identified
in the difference Fourier map and refined freely. In the structure of
6, the main compound contained one disordered (80:20)THF ligand
and the voids contained some solvent which could be modeled as
hexane since the NMR data indicated that hexane was present. Each
main molecule cocrystalized with 1/4 of hexane which was
disordered about a center of inversion. For 7, the sample consisted
of low melting crystals which were selected using a modified device,
similar to that of Veith and Ba¨rnighausen.17 The crystals turned
out to be very weakly diffracting which resulted in a high R(int)
[{H2B(ImtBu)2}Sr{N(SiMe3)2}(THF)2], 6. Compound 1 (1.00
g, 2.6 mmol), strontium iodide (0.88 g, 2.6 mmol) and KN(SiMe3)2
(1.54 g, 7.7 mmol): colorless crystals after 1 day at -20 °C from
hexane (1.85 g, 76%), mp 137-140 °C. 1H NMR ppm (C6D6, 298
K): 7.23 (broad s, 2H, ring-CHdCHNtBu), 6.62 (s, 2H, ring-
CHdCHNtBu), 4.32 (br. s, 2H, BH2), 3.59 (m, 8H, THF), 1.35 (s,
18H, CH3), 1.30 (m, 8H, THF), 0.37 (s, 18H, Si(CH3)3). 13C{1H}
NMR ppm (C6D6 298 K): 201.5 (carbene-C), 126.0 (ring-
CHdCHNtBu), 115.2 (ring-CHdCHNtBu), 69.0 (THF), 55.5
(THF), 32.3 (CCH3), 25.8 (CH3), 5.9 (Si(CH3)3). 11B{1H} NMR
ppm (C6D6 298 K): -5.7. NMR also showed presence of hexane
in the lattice; confirmed by X-ray study. IR (Nujol): υB-H 2363
(16) DENZO-SCALEPACK: Otwinowski Z. and Minor, W. Processing
of X-ray Diffraction Data Collected in Oscillation Mode; Methods in
Enzymology Volume 276: Macromolecular Crystallography, part A; Carter,
C. W., Jr., Sweet R. M., Eds., Academic Press: New York, 1997; pp 307-
326.
(17) Veith, M.; Ba¨rnighausen, H. Acta Crystallogr. B 1974, 30, 1806.
(18) Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837.